380 related articles for article (PubMed ID: 30463956)
1. Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration.
Lim YW; Chen-Harris H; Mayba O; Lianoglou S; Wuster A; Bhangale T; Khan Z; Mariathasan S; Daemen A; Reeder J; Haverty PM; Forrest WF; Brauer M; Mellman I; Albert ML
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11701-E11710. PubMed ID: 30463956
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic contribution to the immune landscape of cancer.
Sayaman RW; Saad M; Thorsson V; Hu D; Hendrickx W; Roelands J; Porta-Pardo E; Mokrab Y; Farshidfar F; Kirchhoff T; Sweis RF; Bathe OF; Heimann C; Campbell MJ; Stretch C; Huntsman S; Graff RE; Syed N; Radvanyi L; Shelley S; Wolf D; Marincola FM; Ceccarelli M; Galon J; Ziv E; Bedognetti D
Immunity; 2021 Feb; 54(2):367-386.e8. PubMed ID: 33567262
[TBL] [Abstract][Full Text] [Related]
3. CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer.
Tian J; Cai Y; Li Y; Lu Z; Huang J; Deng Y; Yang N; Wang X; Ying P; Zhang S; Zhu Y; Zhang H; Zhong R; Chang J; Miao X
Nucleic Acids Res; 2021 Jan; 49(D1):D1065-D1073. PubMed ID: 33010176
[TBL] [Abstract][Full Text] [Related]
4. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
Sweis RF; Galsky MD
Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
[TBL] [Abstract][Full Text] [Related]
6. Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
Yu Y; Zhang W; Li A; Chen Y; Ou Q; He Z; Zhang Y; Liu R; Yao H; Song E
JAMA Netw Open; 2020 Apr; 3(4):e202149. PubMed ID: 32259264
[TBL] [Abstract][Full Text] [Related]
7. Classifying Cancers Based on T-cell Infiltration and PD-L1.
Teng MW; Ngiow SF; Ribas A; Smyth MJ
Cancer Res; 2015 Jun; 75(11):2139-45. PubMed ID: 25977340
[TBL] [Abstract][Full Text] [Related]
8. Germline Features Associated with Immune Infiltration in Solid Tumors.
Shahamatdar S; He MX; Reyna MA; Gusev A; AlDubayan SH; Van Allen EM; Ramachandran S
Cell Rep; 2020 Mar; 30(9):2900-2908.e4. PubMed ID: 32130895
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
Li B; Severson E; Pignon JC; Zhao H; Li T; Novak J; Jiang P; Shen H; Aster JC; Rodig S; Signoretti S; Liu JS; Liu XS
Genome Biol; 2016 Aug; 17(1):174. PubMed ID: 27549193
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of PD-L1 in bladder cancer.
Huang Y; Zhang SD; McCrudden C; Chan KW; Lin Y; Kwok HF
Oncol Rep; 2015 Jun; 33(6):3075-84. PubMed ID: 25963805
[TBL] [Abstract][Full Text] [Related]
11. The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer.
Chan RH; Chen PC; Yeh YM; Lin BW; Yang KD; Shen MR; Lin PC
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204406
[TBL] [Abstract][Full Text] [Related]
12. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Jiang Z; Liu Z; Li M; Chen C; Wang X
EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
[TBL] [Abstract][Full Text] [Related]
13. Cellular immune responses against cancer-germline genes in cancers.
Dashti S; Taherian-Esfahani Z
Hum Antibodies; 2020; 28(1):57-64. PubMed ID: 31356200
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune risk variants in ERAP2 are associated with gene-expression levels in thymus.
Gabrielsen IS; Viken MK; Amundsen SS; Helgeland H; Holm K; Flåm ST; Lie BA
Genes Immun; 2016 Dec; 17(7):406-411. PubMed ID: 27829666
[TBL] [Abstract][Full Text] [Related]
15. Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Varn FS; Schaafsma E; Wang Y; Cheng C
Cancer Res; 2018 Nov; 78(22):6413-6423. PubMed ID: 30254145
[TBL] [Abstract][Full Text] [Related]
16. Potential biomarker for checkpoint blockade immunotherapy and treatment strategy.
Dong ZY; Wu SP; Liao RQ; Huang SM; Wu YL
Tumour Biol; 2016 Apr; 37(4):4251-61. PubMed ID: 26779629
[TBL] [Abstract][Full Text] [Related]
17. A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.
Tamborero D; Rubio-Perez C; Muiños F; Sabarinathan R; Piulats JM; Muntasell A; Dienstmann R; Lopez-Bigas N; Gonzalez-Perez A
Clin Cancer Res; 2018 Aug; 24(15):3717-3728. PubMed ID: 29666300
[No Abstract] [Full Text] [Related]
18. Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait loci.
Miliotis C; Ma Y; Katopodi XL; Karagkouni D; Kanata E; Mattioli K; Kalavros N; Pita-Juárez YH; Batalini F; Ramnarine VR; Nanda S; Slack FJ; Vlachos IS
Nat Commun; 2024 May; 15(1):4319. PubMed ID: 38773080
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.
Cao J; Li J; Yang X; Li P; Yao Z; Han D; Ying L; Wang L; Tian J
Cancer Med; 2021 Aug; 10(15):5375-5391. PubMed ID: 34165261
[TBL] [Abstract][Full Text] [Related]
20. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
